Annual Retained Earnings
-$137.03 M
-$37.94 M-38.29%
31 December 2023
Summary:
Candel Therapeutics annual retained earnings is currently -$137.03 million, with the most recent change of -$37.94 million (-38.29%) on 31 December 2023. During the last 3 years, it has fallen by -$56.73 million (-70.66%). CADL annual retained earnings is now -417.26% below its all-time high of -$26.49 million, reached on 31 December 2019.CADL Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Retained Earnings
-$178.13 M
-$10.65 M-6.36%
30 September 2024
Summary:
Candel Therapeutics quarterly retained earnings is currently -$178.13 million, with the most recent change of -$10.65 million (-6.36%) on 30 September 2024. Over the past year, it has dropped by -$41.10 million (-30.00%). CADL quarterly retained earnings is now -303.28% below its all-time high of -$44.17 million, reached on 31 December 2020.CADL Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CADL Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -30.0% |
| 3 y3 years | -70.7% | -121.8% |
| 5 y5 years | -417.3% | - |
CADL Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -70.7% | at low | -121.8% | at low |
| 5 y | 5 years | -417.3% | at low | -303.3% | at low |
| alltime | all time | -417.3% | at low | -303.3% | at low |
Candel Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -$178.13 M(+6.4%) |
| June 2024 | - | -$167.49 M(+15.3%) |
| Mar 2024 | - | -$145.25 M(+6.0%) |
| Dec 2023 | -$137.03 M(+38.3%) | -$137.03 M(+8.8%) |
| Sept 2023 | - | -$125.93 M(+7.2%) |
| June 2023 | - | -$117.50 M(+8.9%) |
| Mar 2023 | - | -$107.88 M(+8.9%) |
| Dec 2022 | -$99.09 M | -$99.09 M(+5.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | -$94.01 M(+10.2%) |
| June 2022 | - | -$85.32 M(+5.1%) |
| Mar 2022 | - | -$81.17 M(+1.1%) |
| Dec 2021 | -$80.30 M(+81.8%) | -$80.30 M(-1.9%) |
| Sept 2021 | - | -$81.89 M(+24.6%) |
| June 2021 | - | -$65.73 M(+35.1%) |
| Mar 2021 | - | -$48.65 M(+10.1%) |
| Dec 2020 | -$44.17 M(+66.7%) | -$44.17 M |
| Dec 2019 | -$26.49 M | - |
FAQ
- What is Candel Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Candel Therapeutics?
- What is Candel Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Candel Therapeutics?
- What is Candel Therapeutics quarterly retained earnings year-on-year change?
What is Candel Therapeutics annual retained earnings?
The current annual retained earnings of CADL is -$137.03 M
What is the all time high annual retained earnings for Candel Therapeutics?
Candel Therapeutics all-time high annual retained earnings is -$26.49 M
What is Candel Therapeutics quarterly retained earnings?
The current quarterly retained earnings of CADL is -$178.13 M
What is the all time high quarterly retained earnings for Candel Therapeutics?
Candel Therapeutics all-time high quarterly retained earnings is -$44.17 M
What is Candel Therapeutics quarterly retained earnings year-on-year change?
Over the past year, CADL quarterly retained earnings has changed by -$41.10 M (-30.00%)